# Fennec Pharmaceuticals Inc.: Form 8-K, filed Apr 7, 2026

- Company: [Fennec Pharmaceuticals Inc.](/companies/fenc.md) (CIK 1211583)
- Form: 8-K
- Filed: 2026-04-07
- Accepted by EDGAR: Apr 7, 2026, 16:27 ET
- Period: 2026-04-07
- Accession: 0001104659-26-040414
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1211583/000110465926040414/fencf-20260407x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1211583/000110465926040414/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1211583/000110465926040414/fencf-20260407x8k.htm

Filed Apr 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-040414. Last ingested by Listed: Nov 2, 2026, 19:14 ET. No prices; not investment advice.